Safety of human plasma-derived clotting factor products and their role in haemostasis in patients with haemophilia: meeting report.
Tarantino
M
M
Comprehensive Bleeding Disorders Center, 5019 N. Executive Drive, Peoria, IL, USA. mdtara@hemophilia-ctr-peoria.com
Ma
A
A
Aledort
L
L
D000818:Animals; D001779:Blood Coagulation Factors / Q000009:adverse effects*; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy*; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D011994:Recombinant Proteins / Q000009:adverse effects; D016896:Treatment Outcome
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins